If you have hit a roadblock in your weight loss journey, these types of treatments might be exactly what you need
With over 600 million Chinese adults expected to be overweight by 2050, the development of a domestic alternative to Novo Nordisk and Eli Lily's best-selling GLP-1 treatments can make weight loss medications more accessible in the world's second-largest economy
doi: 10.1016/B978-0-12-800101-1.00005-3 54 IzzoAMassiminoERiccardiGDella PepaG
However, its supporting ingredients are slightly more intense
Recently, Eli Lilly reported that tirzepatide combined with a monoclonal antibody (Taltz) can have additive effects for control and reduction of symptoms of plaque psoriasis and psoriatic arthritis, two notoriously difficult to treat autoimmune diseases
Insurance companies typically require documentation showing less than 5% total body weight loss sustained over 3 months, or weight regain after initial loss